Fulcrum Therapeutics, Inc. (FULC) stock
FULCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.75+0.04 (+1.08%)
Close on Nov 17, 2026Market cap $286.12MP/E –Yield –
Fulcrum Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Fulcrum Therapeutics's market cap was $285.31M on Nov 11, 2026, against $591.95M a year earlier. Over the last 5 years it ranged from $130.25M to $960.81M, with a median of $350.51M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $285.31M | -53.4% |
| 2025 | Dec 31, 2025 | $611.97M | +141.4% |
| 2024 | Dec 31, 2024 | $253.51M | -27.9% |
| 2023 | Dec 29, 2023 | $351.67M | -7.2% |
| 2022 | Dec 30, 2022 | $378.92M | -47.1% |
| 2021 | Dec 31, 2021 | $716.90M | +124.4% |
| 2020 | Dec 31, 2020 | $319.43M | -14.9% |
| 2019 | Dec 31, 2019 | $375.36M | – |
See a number that looks wrong?